Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk.
about
Genetics patients' perspectives on clinical genomic testing.Amnestic MCI Patients' Perspectives toward Disclosure of Amyloid PET Results in a Research Context.Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease."I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.Genetic tests: between risks and opportunities. The case of neurodegenerative diseases.Motivators for participation in a whole-genome sequencing study: implications for translational genomics research.The role of distress in uptake and response to predisposition genetic testing: the BMPR2 experienceGenetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic CounselorsNew approaches to genetic counseling and testing for Alzheimer's disease and frontotemporal degenerationTrajectories of preparation for future care among first-degree relatives of Alzheimer's disease patients: an ancillary study of ADAPT.Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience.Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study.A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease.Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.Integrating genomics into clinical oncology: ethical and social challenges from proponents of personalized medicine.Engagement and communication among participants in the ClinSeq Genomic Sequencing Study.Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease.Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses.Personal utility in genomic testing: a systematic literature review.Consumer preferences for the predictive genetic test for Alzheimer disease.Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol.We are the genes we've been waiting for: rational responses to the gathering storm of personal genomics.Personal utility in genomic testing: is there such a thing?The development of a preference-setting model for the return of individual genomic research results.Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context.Overall and domain-specific life satisfaction when living with familial Alzheimer's disease risk: A quantitative approach.The Future Emerges from the Past : Comment on "Personal Genomic Testing, Genetic Inheritance, and Uncertainty".The Fear of Alzheimer's Disease Scale: a new measure designed to assess anticipatory dementia in older adults.Genetic Testing Preferences of Individuals in Families with Essential Tremor.Cancer risk assessment using genetic panel testing: considerations for clinical application.From information to follow-up: Ethical recommendations to facilitate the disclosure of amyloid PET scan results in a research setting.Racial and Ethnic Disparities in Awareness of Cancer Genetic Testing Among Online Users: Internet Use, Health Knowledge, and Socio-Demographic Correlates
P2860
Q33771605-AEADAC98-5F2A-49C3-AE86-FC54CAF75F77Q33840562-382E7E58-DEF0-4B5E-A1F9-2894D9AA5425Q34055651-B299F7B1-2FAD-4CBE-9613-FFCEF1217503Q34065940-A1CF03D3-94AE-493E-96C7-6214BA6A988FQ34394852-94C58CFD-E028-4EB5-BB6E-B84F0962CF81Q35591689-5712D126-DBFD-4738-BFAC-FAE079A8752FQ35836789-95B100DE-80EA-4A76-A308-2DB83BA04CC3Q35889850-E63756BC-7C5F-40EA-8EF8-D0EF127FFCA9Q36218610-A7B48AE9-85DC-40D7-8423-3ABF6F874D5AQ36489092-B7EAE52C-5E91-4CEC-815D-9404053EAE2BQ36790121-ABB80AA9-D9B7-4AFB-8515-2870E34A6709Q37310717-7FE18123-9710-44FB-9F1E-2097A25D6B92Q37346710-51524505-E2C8-4AE9-9451-2DDA6D71BF61Q37406073-FB0FCA9C-DB24-4B8B-BB8B-3396A89E6E25Q37508612-0A6BA0D5-4B9D-40A1-9132-A1330D9AB32AQ37578172-5BAAE8FA-0DA2-4703-A687-ADC511EB6CAEQ37690501-6136D617-6978-445F-8ADA-D88E830157FFQ38719653-1DB7C016-993E-4FDC-85F3-6143D57D6CCDQ38745230-6732E5EB-3C1B-44D6-9FDC-EED2B78739E0Q39224018-DD0FA432-9EFA-4D6A-923C-BB9271EF5504Q40895731-337E25A9-4922-47D8-BAA0-A8FB442456F4Q41950735-AF074D1D-4ACD-44BA-8D72-26BE53648DE5Q45299444-874F8D84-5D35-4D23-95BB-61884670488DQ45304654-2251439B-7C4D-4B89-8E60-D91A5D19E742Q47115002-6485DCB3-129C-4502-82C7-0C9298C423EEQ47754247-D292EEC1-ED13-46A8-9755-B03DED83BD6BQ47850023-AD4771C6-8A84-4738-A204-32A7F4CA13A9Q50621420-0FD5FF40-4D92-4FB2-BA06-F351365762E9Q52614420-745AFEEB-FA55-45D7-B523-9B97E902758CQ53292592-D9D6F5DB-BB91-447F-826C-AD43F6C69097Q55434541-4BC8AD13-655D-47E8-BC97-74A6D1A69B74Q58594545-A49C5757-EF26-408B-A411-9611216CC275
P2860
Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Genetic susceptibility testing ...... to coping with increased risk.
@en
type
label
Genetic susceptibility testing ...... to coping with increased risk.
@en
prefLabel
Genetic susceptibility testing ...... to coping with increased risk.
@en
P2093
P1476
Genetic susceptibility testing ...... to coping with increased risk.
@en
P2093
Barbara B Biesecker
Erin L Linnenbringer
Holly C Gooding
J Scott Roberts
Jeffrey Burack
P304
P356
10.1016/J.PEC.2006.03.002
P577
2006-07-21T00:00:00Z